Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α1A /α1D -Adrenergic Receptor Antagonist with Potential Uroselective Profile

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Vittorio CanalePaweł Zajdel

Abstract

Benign prostatic hyperplasia (BPH) is the most common male clinical problem impacting the quality of life of older men. Clinical studies have indicated that the inhibition of α1A-/α1D adrenoceptors might offer effective therapy in lower urinary tract symptoms. Herein, a limited series of arylsulfonamide derivatives of (aryloxy)ethyl alicyclic amines was designed, synthesized, and biologically evaluated as potent α₁-adrenoceptor antagonists with uroselective profile. Among them, compound 9 (3-chloro-2-fluoro-N-([1-(2-(2-(2,2,2-trifluoroethoxy)phenoxy]ethyl)piperidin-4-yl)methyl)benzenesulfonamide) behaved as an α1A-/α1D-adrenoceptor antagonist (Ki(α₁) = 50 nM, EC50(α1A) = 0.8 nM, EC50(α1D) = 1.1 nM), displayed selectivity over α₂-adrenoceptors (Ki(α₂) = 858 nM), and a 5-fold functional preference over the α1B subtype. Compound 9 showed adequate metabolic stability in rat-liver microsome assay similar to the reference drug tamsulosin (Clint = 67 and 41 µL/min/mg, respectively). Compound 9 did not decrease systolic and diastolic blood pressure in normotensive anesthetized rats in the dose of 2 mg/kg, i.v. These data support development of uroselective agents in the group of arylsulfonamides of alicyclic amines with potential effic...Continue Reading

References

May 5, 2001·Pharmacology & Therapeutics·G A MichelottiD A Schwinn
Sep 17, 2004·The Journal of Urology·Martin C MichelMark Goepel
Mar 15, 2005·Experimental Gerontology·Gerold UntergasserPeter Berger
Jun 23, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Chuang LuLiang-Shang Gan
Feb 29, 2008·International Journal of Urology : Official Journal of the Japanese Urological Association·Debra A Schwinn, Claus G Roehrborn
Jan 6, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Osamu UkimuraUNKNOWN Kyoto Prefectural University of Medicine Benign Prostatic Hypertrophy Research Group
Oct 29, 2009·Cellular and Molecular Life Sciences : CMLS·James R Docherty
Jan 1, 2010·American Journal of Physiology. Renal Physiology·Chen-Li Cheng, William C de Groat
Jun 21, 2012·European Journal of Drug Metabolism and Pharmacokinetics·Mahmud KajbafStefano Fontana
Jun 5, 2013·International Journal of Urology : Official Journal of the Japanese Urological Association·Kenya YamaguchiSatoru Takahashi
Sep 17, 2013·Neurourology and Urodynamics·Martin HennenbergChristian Gratzke
Nov 6, 2013·Current Medical Research and Opinion·Fabio CastiglioneFrancesco Montorsi
Apr 20, 2014·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Nishant D Patel, J Kellogg Parsons
Mar 31, 2015·Bioorganic & Medicinal Chemistry·Paula ZarębaKatarzyna Kulig

❮ Previous
Next ❯

Citations

Sep 17, 2020·Antibiotics·Cory T ReidlDaniel P Becker
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Vittorio CanalePaweł Zajdel

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
Assay

Software Mentioned

Graph Pad
MassLynx
GraphPad
GraphPadPrism
Graph Pad Prism

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.